| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |